SCHEMBL6887143

SCHEMBL6887143

c1ccc(-c2cnc(NC3CCCCC3)nc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.59
▸ GAA P10253 1/20 0.59
▸ ADORA1 P30542 1/20 0.54
▸ HDAC3 O15379 1/20 0.50
▸ HDAC1 Q13547 1/20 0.50
▸ HDAC2 Q92769 1/20 0.50
▸ HDAC6 Q9UBN7 1/20 0.50
▸ ACHE P22303 1/20 0.49
▸ NPC1 O15118 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ PAK1 Q13153 1/20 0.48
▸ MERTK Q12866 3/20 0.47
▸ PDE5A O76074 2/20 0.47
▸ ACP1 P24666 2/20 0.47
▸ MAPT P10636 1/20 0.47
▸ AXL P30530 1/20 0.46
▸ FLT3 P36888 1/20 0.46
▸ TYRO3 Q06418 1/20 0.46
▸ GAS6 Q14393 1/20 0.46
▸ CTSK P43235 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6886534 0.98 KDM4E (0.56) KDM4EGAAADORA1HDAC3HDAC1
SCHEMBL6885119 0.83 MAPK1 (0.62) ADORA1HDAC3HDAC1HDAC2HDAC6
SCHEMBL6885645 0.83 GRM5 (0.48) ADORA1HDAC1ACHENPC1RAB9A
SCHEMBL16691171 0.83 KDM4E (0.51) KDM4EGAAADORA1HDAC3HDAC1
SCHEMBL6884017 0.83 ADORA1 (0.60) ADORA1MERTKAXLFLT3TYRO3
SCHEMBL6886667 0.83 ADORA1 (0.60) ADORA1MERTKAXLFLT3TYRO3
SCHEMBL13062703 0.83 HDAC1 (0.56) ADORA1HDAC1MAPT
SCHEMBL1035407 0.83 FYN (0.55) KDM4EGAAADORA1HDAC3HDAC1
Hydrochloric Acid SCHEMBL3776468 0.82 HDAC1 (0.55) ADORA1HDAC1MAPT
SCHEMBL6888147 0.80 MERTK (0.46) ADORA1HDAC1ACHEMERTKMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8389536-B2 Positive allosteric modulators (PAM) HOFFMANN-LA ROCHE INC. (US) 2013-03-05 — — US disclosed
US-20110098313-A1 POSITIVE ALLOSTERIC MODULATORS (PAM) HOFFMANN-LA ROCHE, INC. 2011-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098313-A1 POSITIVE ALLOSTERIC MODULATORS (PAM) GRM5, GRM1, GRM2 KDM4E 2603/4885GAA 3545/4885ADORA1 161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback